Vanguard Group Inc. lifted its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,969,754 shares of the company’s stock after purchasing an additional 1,211,418 shares during the quarter. Vanguard Group Inc. owned about 0.09% of Avantor worth $1,347,843,000 at the end of the most recent quarter.
Several other hedge funds have also recently modified their holdings of AVTR. MassMutual Private Wealth & Trust FSB raised its position in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its position in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the period. UMB Bank n.a. boosted its holdings in Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC acquired a new position in Avantor during the 4th quarter worth approximately $65,000. 95.08% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Avantor
In other news, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Steven W. Eck sold 4,907 shares of the company’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Get Our Latest Stock Analysis on AVTR
Avantor Trading Down 0.7 %
Shares of AVTR opened at $16.17 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor, Inc. has a 1-year low of $15.37 and a 1-year high of $28.00. The stock has a market cap of $11.01 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The firm has a 50 day simple moving average of $18.52 and a 200-day simple moving average of $21.49.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the prior year, the business earned $0.22 earnings per share. Equities analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How to Invest in the FAANG Stocks
- Top 3 Beverage Stocks Pouring Out Profits
- The 3 Best Blue-Chip Stocks to Buy Now
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.